| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Bridgewater Associates · Ray Dalio | $3.9M | 0.02% | 369.97K | New | Q2 2026 |
| ARK Investment Management · Cathie Wood | $2.5M | 0.02% | 235.54K | −12% | Q2 2026 |
| Renaissance Technologies | $355.0K | 0.00% | 33.46K | −98% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | 2 | −$16.0K | Sold Jan 8, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Jan 8, 25 | Gilbert Cisneros CA31 | Self | Sell | $1,001 - $15,000 | Feb 11, 25 (34d) | |
| Jan 7, 25 | Gilbert Cisneros CA31 | Self | Sell (part) | $1,001 - $15,000 | Feb 11, 25 (35d) |
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 9, 2026 | Fortson John CChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 24K | — |
| Jun 14, 2026 | Hosein Clyde RDirector | Purchase at price 9.98 per share. | 6.5K | $64.90K |
| Jun 14, 2026 | Gladden Brian TDirector | Purchase at price 10.02 per share. | 10K | $100.00K |
| Jun 11, 2026 | Mazelsky Jonathan JayDirector | Stock Award(Grant) at price 10.14 per share. | 10K | $101.40K |
| Jun 11, 2026 | Mazelsky Jonathan JayDirector | Purchase at price 10.14 per share. | 10K | $101.40K |
| Jun 11, 2026 | Mckeon Brian PDirector | Purchase at price 10.12 per share. | 10K | $101.20K |
| Jun 10, 2026 | Barber Michael JDirector | Purchase at price 9.88 per share. | 15.2K | $150.00K |
| Jun 10, 2026 | Holden Betsy DDirector | Purchase at price 9.88 per share. | 10.1K | $99.69K |
| Jun 2, 2026 | Mazelsky Jonathan JayDirector | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Jun 2, 2026 | Vergis Janet SDirector | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Jun 2, 2026 | Varon Leslie F.Director | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Jun 2, 2026 | Hosein Clyde RDirector | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Jun 2, 2026 | Barber Michael JDirector | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Jun 2, 2026 | Lucier Gregory TDirector | Stock Award(Grant) at price 0.00 per share. | 38.4K | — |
| Jun 2, 2026 | Lucier Gregory TDirector | Stock Gift at price 0.00 per share. | 38.4K | — |
| Jun 2, 2026 | Holden Betsy DDirector | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Jun 2, 2026 | Mckeon Brian PDirector | Stock Award(Grant) at price 0.00 per share. | 28.9K | — |
| Jun 2, 2026 | Zurbay Donald JDirector | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Jun 2, 2026 | Gladden Brian TDirector | Stock Award(Grant) at price 0.00 per share. | 22.8K | — |
| Jun 2, 2026 | Forbes James DDirector | Stock Award(Grant) at price 0.00 per share. | 28.9K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 9.1 | 17.7 | -21.0 | 1.3 | -10.9 | 1.3 | 26.0 | -16.5 | -20.7 | -3.7 | −25.4% | ||
| 2025 | 4.1 | -16.2 | -9.7 | -7.0 | 15.0 | -0.6 | -9.9 | -0.1 | -11.3 | -0.6 | -10.1 | 0.8 | −39.8% |
| 2024 | -2.4 | -6.0 | 1.6 | -9.6 | -6.7 | -11.1 | 9.0 | -6.8 | 7.0 | -14.4 | -15.2 | -3.4 | −46.7% |
| 2023 | 15.7 | 3.4 | 3.2 | 6.7 | -13.9 | 10.8 | 3.7 | -10.7 | -7.9 | -11.0 | 4.4 | 12.1 | +11.8% |
| 2022 | -4.2 | 1.3 | -9.1 | -18.8 | -1.1 | -9.7 | 1.2 | -9.4 | -13.5 | 8.7 | -1.8 | 5.2 | −42.9% |
| 2021 | 2.2 | -0.8 | 20.2 | 5.8 | -0.9 | -5.5 | 4.4 | -6.6 | -5.9 | -1.4 | -14.8 | 14.5 | +6.6% |
| 2020 | -1.0 | -12.1 | -21.1 | 9.3 | 9.6 | -5.3 | 1.2 | 0.6 | -2.5 | 7.9 | 7.8 | 2.9 | −7.5% |
| 2019 | 12.7 | -0.5 | 18.8 | 3.1 | 5.4 | 8.3 | -6.7 | -4.2 | 2.2 | 2.8 | 3.2 | 0.1 | +52.1% |
| 2018 | -7.6 | -7.8 | -10.3 | 0.1 | -13.0 | -0.1 | 9.9 | -17.0 | -5.5 | -8.2 | 9.1 | -1.5 | −43.5% |
| 2017 | -1.8 | 12.0 | -1.7 | 1.3 | 0.4 | 2.1 | -4.3 | -8.8 | 5.7 | 2.1 | 9.7 | -1.8 | +14.0% |
| 2016 | -3.2 | 3.5 | 1.1 | -3.3 | 4.3 | -0.2 | 3.2 | -4.0 | -3.3 | -3.1 | 1.1 | -0.8 | −5.1% |
| 2015 | -6.1 | 6.0 | -4.0 | 0.2 | 2.0 | -0.9 | 10.4 | -7.9 | -3.5 | 20.3 | -0.3 | 0.3 | +14.2% |
| 2014 | -4.8 | -1.6 | 1.5 | -3.1 | 6.0 | 0.1 | -2.0 | 2.8 | -4.4 | 11.3 | 8.3 | -3.1 | +9.9% |
| 2013 | 5.4 | -0.8 | 2.5 | -0.2 | -1.4 | -1.9 | 4.7 | -2.1 | 3.4 | 8.5 | 1.0 | 1.9 | +22.4% |
| 2012 | 7.9 | 2.6 | 3.7 | 2.3 | -9.9 | 2.2 | -3.9 | -0.2 | 5.2 | -3.4 | 7.8 | -0.2 | +13.2% |
| 2011 | 3.8 | 5.3 | -1.0 | 1.5 | 4.5 | -3.0 | -0.5 | -7.1 | -12.8 | 20.4 | -2.3 | -3.1 | +2.4% |
| 2010 | -4.7 | -1.3 | 5.4 | 5.1 | -11.5 | -7.8 | 0.4 | -7.5 | 15.1 | -1.8 | -1.5 | 10.5 | −2.8% |
| 2009 | -4.7 | -14.1 | 16.1 | 6.6 | 2.2 | 4.5 | 9.1 | 1.1 | 2.4 | -4.6 | 1.1 | 5.6 | +24.5% |
| 2008 | -8.2 | -5.5 | -1.1 | 0.7 | 4.3 | -9.2 | 9.4 | -2.6 | -4.2 | -19.1 | -14.2 | 8.3 | −37.3% |
| 2007 | 3.3 | 2.3 | 3.8 | 2.0 | 8.2 | 5.8 | -4.6 | 7.9 | 5.7 | -0.4 | 3.1 | 5.2 | +50.8% |
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
Buy / hold / sell counts